26
Sun, May
62 New Articles

Deal 5: Dr. Max Head of Group M&A Ivo Senkyrik on A&D Pharma Acquisition in Romania

Deal 5: Dr. Max Head of Group M&A Ivo Senkyrik on A&D Pharma Acquisition in Romania

Deal 5
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

On January 2, 2018, CEE Legal Matters reported that Czech pharmacy chain Dr. Max acquired the entire A&D Pharma network in Romania, in a transaction that has been shortlisted for CEE Deal of the Year 2017 in the country. While the transaction awaits approval from authorities, we reached out to Ivo Senkyrik, Head of Group M&A at Dr. Max, to find out how his team made the deal happen.

CEELM: Did the A&D Pharma shareholders initiate the sale, or did Penta Investments? Does that effect the nature of the negotiations and the process of the sale in any way?

I.S: Dr. Max and our shareholder (Penta Investment) had been considering entering the Romanian market due to the current and expected development of the Romanian pharma industry and the macro environment. Our interest materialized through our first acquisition of 31 pharmacies, in the first half of 2017. As our strategy is to be the market leader in countries where we operate, we were considering several other acquisition opportunities. A&D is a leading player in the market thus it was clearly a primary acquisition target for Dr. Max. We initiated the contact with them.

CEELM: How is the integration of Dr. Max and A&D legal teams going?

I.S: Currently, there is no integration of any part of the business. The transaction will only be completed after the approval of the competition authorities in the relevant countries. The integration process will thus not begin until these approvals are received and the transaction is completely settled.

CEELM: You are based in the Czech Republic — how did you perform the search for a legal support in Romania? What led you to choose Musat & Asociatii for this deal? 

I.S: Historically, we worked together with Musat on [a previous] pharma deal. Thanks to this historical experience, we believed that [the firm] could bring value to the A&D transaction, so we decided to select Musat as our legal buy-side advisors.

CEELM: What was Musat &Asociatii’s mandate in the matter, exactly? Did the firm exceed your expectations in any way, or was the mandate simple, and their execution functional and effective? Can you elaborate?

I.S: Their engagement included complete transaction advisory related to legal matters of the M&A process (assistance with legal due diligence and transaction documentation). The due diligence phase was fully covered by Musat given their experience with the local environment. In a later stage of the process, especially during the transaction negotiation, their team was cooperating very closely with our long-term law firm from the Czech Republic – Jan Evan – who has very good knowledge of our group and requirements. Legal due diligence of non-Romanian business were covered by other top tier law firms in respective countries.

CEELM: It seems that recently there is much consolidation goes on in the pharma sector in CEE. Do you think that this consolidation might raise competition concerns?

I.S: From my perspective, the consolidation is quite a natural process in almost any industry due the fact that the world is currently spinning faster. If you compare the development of industries several decades ago with the current pace and business changes which the industries are facing now, we can see big differences in many sectors. So if you want to be an industry leader you need to work continuously on organic growth but also to speed up the growth through acquisitions, while concurrently considering how to minimize the overall risk through diversification.

With respect to the competition concerns, I do not think that consolidation is wrong, [as long as] such consolidation does not result in the complete removal of competition in the market. I believe that if the consolidation is conducted at a reasonable level, ultimately the final customers should benefit from the consolidation. The market leaders can provide a different level of customer experience, broaden services, and provide higher quality to their customers. At least, Dr. Max can deliver these positive aspects to the customers thanks to the consolidation.

 

Czech Republic Knowledge Partner

PRK Partners, one of the leading Central European law firms, has been helping clients achieve their business objectives almost 30 years. Our team of lawyers, based in our Prague, Ostrava, and Bratislava offices, has a unique knowledge of Czech and Slovak law and of the business environment. Our lawyers studied at top law schools in the United States, United Kingdom, Switzerland and elsewhere. They also have experience working for leading international and domestic law firms in a number of jurisdictions. We speak your language, too. Our legal team is fluent in more than 15 languages, including all the key languages of the region.

PRK Partners has one of the most experienced legal teams on the market. We are consistently rated as one of the leading law firms in the region. We have received many significant honours and awards for our work. We represent the interests of international clients operating in the Czech Republic in an efficient way, combining local knowledge with an understanding of their global requirements in a business-friendly approach. We are one of the largest law firms in the Czech Republic and Slovakia. Our specialised teams of lawyers and tax advisors advise major global corporations as well as local companies. We provide comprehensive legal advice drawing on our profound knowledge of local law and markets.

Our legal advice delivers tangible results – as proven by our strong track record. We are the only Czech member firm of Lex Mundi, the world's leading network of independent law firms. As one of the leading law firms in the region, we have received many national and international awards, in some cases several years in a row. Honours include the Chambers Europe Award for Excellence, The Lawyer and Czech and Slovak Law Firm of the Year. Thanks to our close cooperation with leading international law firms and strong local players, we can serve clients in multiple jurisdictions around the globe. Our strong network means that we can meet your needs, wherever you do business.

PRK Partners has been repeatedly voted among the most socially responsible firms in the category of small and mid-sized firms and was awarded the bronze certificate at the annual TOP Responsible Firm of the Year Awards.

Our work is not only “business”: we have participated on a longstanding basis in a wide variety of pro bono projects and supported our partners from the non-profit sector (Kaplicky Centre Endowment Fund, Tereza Maxová Foundation, Czech Donors Forum, etc.).

Firm's website: www.prkpartners.com

Our Latest Issue